Washington Capital Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-5,870
Closed -$444K 118
2026
Q1
$444K Sell
5,870
-3,250
-36% -$244K 0.37% 82
2025
Q4
$679K Sell
9,120
-7,780
-46% -$568K 0.55% 47
2025
Q3
$1.14M Sell
16,900
-445
-3% -$29.5K 0.81% 27
2025
Q2
$1.13M Buy
17,345
+1,900
+12% +$114K 0.84% 24
2025
Q1
$954K Buy
15,445
+7,515
+95% +$498K 0.77% 29
2024
Q4
$572K Hold
7,930
0.45% 68
2024
Q3
$646K Hold
7,930
0.5% 51
2024
Q2
$589K Hold
7,930
0.5% 60
2024
Q1
$618K Buy
+7,930
New +$590K 0.5% 58
2016
Q2
Sell
-12,200
Closed -$421K 100
2016
Q1
$421K Hold
12,200
0.31% 97
2015
Q4
$472K Hold
12,200
0.29% 93
2015
Q3
$477K Hold
12,200
0.3% 89
2015
Q2
$464K Hold
12,200
0.26% 97
2015
Q1
$403K Buy
+12,200
New +$374K 0.23% 103

Other funds holding HOLX

Washington Capital Management's HOLX Position: Q2 2026 in Review

Washington Capital Management sold out of Hologic (HOLX) in Q2 2026, closing a stake of 5,870 shares — an estimated $444K sold.

Washington Capital Management first reported a position in HOLX in Q1 2015 and held it in 14 quarters. The position peaked at $1.14M in Q3 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Washington Capital Management reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Washington Capital Management sold 5,870 Hologic shares in Q2 2026, an estimated $444K.
  • Washington Capital Management first reported a position in Hologic in Q1 2015 and held it in 14 quarters.
  • Washington Capital Management's Hologic position peaked at $1.14M in Q3 2025.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Washington Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.